{"id":"https://openalex.org/W2000922813","doi":"https://doi.org/10.1021/jm00097a012","title":"6-Substituted decahydroisoquinoline-3-carboxylic acids as potent and selective conformationally constrained NMDA receptor antagonists","display_name":"6-Substituted decahydroisoquinoline-3-carboxylic acids as potent and selective conformationally constrained NMDA receptor antagonists","publication_year":1992,"publication_date":"1992-09-01","ids":{"openalex":"https://openalex.org/W2000922813","doi":"https://doi.org/10.1021/jm00097a012","mag":"2000922813","pmid":"https://pubmed.ncbi.nlm.nih.gov/1404235"},"language":"en","primary_location":{"id":"doi:10.1021/jm00097a012","doi":"https://doi.org/10.1021/jm00097a012","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm00097a012","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036532125","display_name":"Paul L. Ornstein","orcid":"https://orcid.org/0000-0002-4335-1877","observed_orcids":["https://orcid.org/0000-0002-4335-1877"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul L. Ornstein","raw_affiliation_strings":["Lilly Research Laboratories, Division of Eli Lilly and Company, Indianapolis, Indiana 46285"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Division of Eli Lilly and Company, Indianapolis, Indiana 46285","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055799927","display_name":"Darryle D. Schoepp","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Darryle D. Schoepp","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110145956","display_name":"M. Brian Arnold","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Brian Arnold","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027585495","display_name":"Nancy K. Augenstein","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nancy K. Augenstein","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112950198","display_name":"David Lodge","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Lodge","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038217626","display_name":"John D. Millar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John D. Millar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"John Chambers","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Chambers","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111618621","display_name":"Jack B. Campbell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jack Campbell","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5113212953","display_name":"Jonathan W. Paschal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jonathan W. Paschal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":0.985,"has_fulltext":false,"cited_by_count":38,"citation_normalized_percentile":{"value":0.73605809,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"35","issue":"19","first_page":"3547","last_page":"3560"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9404000043869019,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9404000043869019,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13971","display_name":"Isoquinoline Alkaloid Synthesis","score":0.01640000008046627,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12770","display_name":"Amino Acid Enzymes and Metabolism","score":0.00930000003427267,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nmda-receptor-antagonist","display_name":"NMDA receptor antagonists","score":0.9520000219345093},{"id":"https://openalex.org/keywords/conformationally-constrained-amino-acids","display_name":"conformationally constrained amino acids","score":0.9089999794960022},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.7509999871253967},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.7749999761581421},{"id":"https://openalex.org/keywords/excitotoxicity","display_name":"excitotoxicity","score":0.9430000185966492},{"id":"https://openalex.org/keywords/glutamate","display_name":"glutamate","score":0.5339999794960022},{"id":"https://openalex.org/keywords/diastereomers","display_name":"diastereomers","score":0.8560000061988831},{"id":"https://openalex.org/keywords/neurodegenerative-diseases","display_name":"neurodegenerative diseases","score":0.7889999747276306}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9489877223968506},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.8234239816665649},{"id":"https://openalex.org/C2779074116","wikidata":"https://www.wikidata.org/wiki/Q134856","display_name":"Carboxylic acid","level":2,"score":0.5787320733070374},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.544738233089447},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.49150216579437256},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4361254870891571},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.23949888348579407},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001665","descriptor_name":"Binding Sites","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001667","descriptor_name":"Binding, Competitive","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002264","descriptor_name":"Carboxylic Acids","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D002264","descriptor_name":"Carboxylic Acids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002264","descriptor_name":"Carboxylic Acids","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D007546","descriptor_name":"Isoquinolines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D007546","descriptor_name":"Isoquinolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007546","descriptor_name":"Isoquinolines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D008968","descriptor_name":"Molecular Conformation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013237","descriptor_name":"Stereoisomerism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/jm00097a012","doi":"https://doi.org/10.1021/jm00097a012","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm00097a012","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:1404235","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1404235","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.5683000087738037}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320321040","display_name":"National Science Council","ror":"https://ror.org/02kv4zf79"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2952956924","https://openalex.org/W2097047268","https://openalex.org/W2088700160","https://openalex.org/W2096375567","https://openalex.org/W1994296594","https://openalex.org/W2017744581","https://openalex.org/W2952515912","https://openalex.org/W2071392015","https://openalex.org/W2018701979","https://openalex.org/W1991565857"],"abstract_inverted_index":{"We":[0,105],"have":[1],"prepared":[2,54],"a":[3,20,36,71,197,260],"series":[4],"of":[5,23,29,38,47,108,112,179,203,227,241,262],"6-substituted":[6],"decahydroisoquinoline-3-carboxylic":[7],"acids,":[8],"and":[9,40,66,69,78,85,122,131,144,151,156,171,183,189,207,216,229,250],"structurally":[10],"similar":[11],"analogs,":[12],"as":[13,32,133,256],"potential":[14],"N-methyl-D-aspartate":[15],"receptor":[16,61,130,147],"antagonists.":[17,135],"There":[18],"is":[19],"large":[21],"body":[22],"evidence":[24],"to":[25,81,99,118,194],"support":[26],"the":[27,109,113,120,128,149,242],"use":[28],"such":[30],"compounds":[31,53,214],"cerebroprotective":[33],"agents":[34,258],"in":[35,57,59,70,94,103,116,163,196,221],"variety":[37],"acute":[39],"chronic":[41],"neurodegenerative":[42],"disorders,":[43],"where":[44],"some":[45,240],"component":[46],"glutamate-mediated":[48],"excitotoxicity":[49],"may":[50],"exist.":[51],"The":[52,87],"were":[55,91],"evaluated":[56,93],"vitro":[58],"both":[60],"binding":[62,176],"assays":[63],"([3H]CGS19755,":[64],"[3H]AMPA,":[65],"[3H]kainic":[67],"acid)":[68,80],"cortical":[72,198],"wedge":[73,199],"preparation":[74,200],"(versus":[75],"NMDA,":[76],"AMPA,":[77],"kainic":[79],"determine":[82],"affinity,":[83],"potency,":[84],"selectivity.":[86],"new":[88],"amino":[89,153,236],"acids":[90,154,237],"also":[92],"vivo":[95],"for":[96,125,254,259],"their":[97],"ability":[98],"block":[100],"NMDA-induced":[101,219],"lethality":[102,220],"mice.":[104],"synthesized":[106],"many":[107],"possible":[110],"diastereomers":[111],"decahydroisoquinoline":[114],"nucleus":[115],"order":[117],"examine":[119],"spatial":[121],"steric":[123],"requirements":[124],"affinity":[126],"at":[127],"NMDA":[129,134,146,195,245],"activity":[132,162],"From":[136],"our":[137],"structure-activity":[138],"relationship":[139],"we":[140],"identified":[141],"two":[142],"potent":[143,244],"selective":[145],"antagonists,":[148],"phosphonate-":[150],"tetrazole-substituted":[152],"31a":[155,170,215],"32a,":[157],"respectively,":[158,188],"that":[159],"show":[160],"good":[161],"animals":[164],"following":[165],"systemic":[166],"administration.":[167],"For":[168],"example,":[169],"32a":[172,217],"selectively":[173,190],"displaced":[174],"[3H]CGS19755":[175],"with":[177,201,223],"IC50S":[178,202],"55":[180],"+/-":[181,185,205,209],"14":[182],"856":[184],"136":[186],"nM,":[187],"antagonized":[191],"responses":[192],"due":[193],"0.15":[204],"0.01":[206],"1.39":[208],"0.29":[210],"microM,":[211],"respectively.":[212,233],"And":[213],"blocked":[218],"mice":[222],"minimum":[224],"effective":[225],"doses":[226],"1.25":[228],"2.5":[230],"mg/kg":[231],"(intraperitoneal),":[232],"These":[234],"novel":[235],"are":[238,251],"among":[239],"most":[243],"antagonists":[246],"described":[247],"thus":[248],"far,":[249],"excellent":[252],"candidates":[253],"development":[255],"neuroprotective":[257],"number":[261],"CNS":[263],"disorders.":[264]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}